Correlation Between Pharmaceuticals Ultrasector and Boston Partners

Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Boston Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Boston Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Boston Partners Longshort, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Boston Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Boston Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Boston Partners.

Diversification Opportunities for Pharmaceuticals Ultrasector and Boston Partners

0.75

Correlation Coefficient

Pharmaceuticals Ultrasector  Boston Partners

Poor diversification

The 3 months correlation between Pharmaceuticals and Boston is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Boston Partners Longshort in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Boston Partners Longshort and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Boston Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Boston Partners Longshort has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Boston Partners go up and down completely randomly.

Pair Corralation between Pharmaceuticals Ultrasector and Boston Partners

Assuming the 90 days horizon Pharmaceuticals Ultrasector Profund is expected to generate 4.19 times more return on investment than Boston Partners. However, Pharmaceuticals Ultrasector is 4.19 times more volatile than Boston Partners Longshort. It trades about 0.13 of its potential returns per unit of risk. Boston Partners Longshort is currently generating about 0.33 per unit of risk. If you would invest  2,016  in Pharmaceuticals Ultrasector Profund on April 20, 2025 and sell it today you would earn a total of  305.00  from holding Pharmaceuticals Ultrasector Profund or generate 15.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.41%
Values	Daily Returns

Pharmaceuticals Ultrasector Pr  vs.  Boston Partners Longshort

Pharmaceuticals Ultrasector

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Ultrasector Profund are ranked lower than 9 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Pharmaceuticals Ultrasector showed solid returns over the last few months and may actually be approaching a breakup point.

Boston Partners Longshort

Risk-Adjusted Performance

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Boston Partners Longshort are ranked lower than 26 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Boston Partners may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with Pharmaceuticals Ultrasector and Boston Partners

The main advantage of trading using opposite Pharmaceuticals Ultrasector and Boston Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Boston Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boston Partners will offset losses from the drop in Boston Partners' long position.

The idea behind Pharmaceuticals Ultrasector Profund and Boston Partners Longshort pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.